Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
NASDAQ:ENTX
Price:
1.98 USD
-1%
Market Closed
Updated:
Apr 29, 2024
Entera Bio Ltd
Cash from Investing Activities
|
Entera Bio Ltd
Cash from Investing Activities Peer Comparison
Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Cash from Investing Activities
-$17k
|
CAGR 3-Years
30%
|
CAGR 5-Years
67%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Cash from Investing Activities
-$1.2m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Cash from Investing Activities
-$5.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Cash from Investing Activities
$1.4m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Cash from Investing Activities
-$953k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Cash from Investing Activities
-₪11m
|
CAGR 3-Years
-485%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
-20%
|
See Also
What is Entera Bio Ltd's Cash from Investing Activities?
Cash from Investing Activities
-17k
USD
-17k
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Cash from Investing Activities amounts to -17k USD.
What is Entera Bio Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
67%
67%
Over the last year, the Cash from Investing Activities growth was 83%. The average annual Cash from Investing Activities growth rates for Entera Bio Ltd have been 30% over the past three years , 67% over the past five years .
You don't have any saved screeners yet
